The Seventh Prevention of Syncope Trial (POST VII)—A randomized clinical trial of atomoxetine for the prevention of vasovagal syncope: Rationale and study design-Reference-Cited by-同舟云学术

The Seventh Prevention of Syncope Trial (POST VII)—A randomized clinical trial of atomoxetine for the prevention of vasovagal syncope: Rationale and study design

Published:2023-08 Issue: Volume:262 Page:49-54
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Sandhu Roopinder K.^ORCID,Raj Satish R.,Hamzeh Rasha,Sheldon Robert S.

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years;Ganzeboom;J Cardiovasc Electrophysiol,2006

2. Vasovagal syncope in medical students and their first-degree relatives;Serletis;Eur Heart J,2006

3. Syncope prevalence in the ED compared to general practice and population: a strong selection process;Olde Nordkamp;Am J Emerg Med,2009

4. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society;Shen;J Am Coll Cardiol,2017

5. The relationship between health-related quality of life and frequency of spells in patients with syncope;Rose;J Clin Epidemiol,2000

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of sleep syncope and vagally-mediated asystole by norepinephrine transporter inhibitor;HeartRhythm Case Reports;2024-06